$PMCB Phase 1 - Pharmacyte Biotech Inc research using Melligen Cells
Project Member(s): Simpson, A. Funding or Partner Organisation: Pharmacyte Biotech Inc Start year: 2015 Summary: This is a first phase engagement with Pharmacyte Biotech Inc (a US based cell therapy company formerly known as Nuvilex) around investigating the in vitro and in vivo performance of UTS technology (Melligen Cells for diabetes treatment) once encapsulated. Future phases may result in more detailed in vitro and in vivo studies investigating the encapsulated Melligen cells. Pharmacyte, Pharmacyte Biotech, Nuvilex, Melligen, Diabetes, Simpson Regenerative Medicine (incl. Stem Cells and Tissue Engineering), Diabetes http://cfsites1.uts.edu.au/find/projects/detail.cfm?ProjectId=2014000473
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.